Contents
Current Cancer Drug Targets, Volume 11 - Number 6
Esophagogastric Cancer: Integration of Targeted Therapies into Systemic Chemotherapy
, 11(6): 681 - 687M. Moehler, S. Schwarz and A. D. Wagner
DOI: 10.2174/156800911796191006
Molecular Targeted Therapy of Gastrointestinal Stromal Tumors
, 11(6): 688 - 697P. Reichardt, A. Reichardt and D. Pink
DOI: 10.2174/156800911796191042
Novel Approaches to Target Pancreatic Cancer
, 11(6): 698 - 713M. Porzner and T. Seufferlein
DOI: 10.2174/156800911796191079
Molecular Targeted Therapy of Hepatocellular Carcinoma – Results of the First Clinical Studies
, 11(6): 714 - 733M. W. Wiedmann and J. Mossner
DOI: 10.2174/156800911796191033
Myeloid-Derived Suppressor Cells: General Characteristics and Relevance to Clinical Management of Pancreatic Cancer
, 11(6): 734 - 751P. Goedegebuure, J. B. Mitchem, M. R. Porembka, M. C.B. Tan, B. A. Belt, A. Wang-Gillam, W. E. Gillanders, W. G. Hawkins and D. C. Linehan
DOI: 10.2174/156800911796191024
Polyisoprenylation Potentiates the Inhibition of Polyisoprenylated Methylated Protein Methyl Esterase and the Cell Degenerative Effects of Sulfonyl Fluorides
, 11(6): 752 - 762B. Aguilar, F. Amissah, R. Duverna and N. S. Lamango
DOI: 10.2174/156800911796191015
α2-Adrenoceptors Enhance Cell Proliferation and Mammary Tumor Growth Acting Through both the Stroma and the Tumor Cells
, 11(6): 763 - 774A. Bruzzone, C. Perez Pinero, P. Rojas, M. Romanato, H. Gass, C. Lanari and I. A. Luthy
DOI: 10.2174/156800911796191051
Webmaster Contact: info@benthamscience.net